Dengue Vaccine Availability by Mid-2026

Indian Immunologicals announced that they are nearing commercial release of dengue vaccine.

Key Points

Dengue Vaccine Progress: Indian Immunologicals completes phase 1 trials, eyes mid-2026 release for dengue vaccine.
Upcoming Trials: Second and third phases to assess vaccine efficacy set to commence soon after successful safety trials.
Expansion of Portfolio: Company also developing vaccines for Zika virus and Kyasanur Forest Disease (KFD).
Collaboration with ICMR: Indian Council of Medical Research supports clinical trials for Zika vaccine, discusses co-development for KFD vaccine.
Product Launch: Havisure, Hepatitis A vaccine, launched successfully in January. Prefilled syringe production underway to meet demand.